Barclays
INFU icon

Barclays’s InfuSystem Holdings INFU Stock Holding History

Barclays’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.8K Sell
9,000
-14,286
-61% -$135K ﹤0.01% 4104
2026
Q1 		$215K Sell
23,286
-2,026
-8% -$17.7K ﹤0.01% 3648
2025
Q4 		$227K Buy
25,312
+13,207
+109% +$126K ﹤0.01% 4248
2025
Q3 		$125K Sell
12,105
-2,289
-16% -$19K ﹤0.01% 4543
2025
Q2 		$89.8K Sell
14,394
-14,583
-50% -$80.6K ﹤0.01% 4607
2025
Q1 		$156K Sell
28,977
-2,502
-8% -$18.3K ﹤0.01% 4176
2024
Q4 		$266K Buy
31,479
+2,882
+10% +$22.7K ﹤0.01% 4171
2024
Q3 		$192K Buy
28,597
+21,457
+301% +$139K ﹤0.01% 4323
2024
Q2 		$48.8K Sell
7,140
-6,074
-46% -$44.6K ﹤0.01% 4220
2024
Q1 		$113K Sell
13,214
-12,424
-48% -$117K ﹤0.01% 4388
2023
Q4 		$270K Buy
25,638
+21,706
+552% +$213K ﹤0.01% 4275
2023
Q3 		$37.9K Buy
3,932
+279
+8% +$2.85K ﹤0.01% 3976
2023
Q2 		$35.2K Buy
+3,653
New +$33.1K ﹤0.01% 3981
2022
Q2 		– Sell
-2,943
Closed -$29K – 5141
2022
Q1 		$29K Sell
2,943
-19,038
-87% -$245K ﹤0.01% 4312
2021
Q4 		$374K Buy
21,981
+14,579
+197% +$231K ﹤0.01% 3324
2021
Q3 		$97K Buy
7,402
+1,071
+17% +$17.5K ﹤0.01% 3909
2021
Q2 		$131K Sell
6,331
-10,160
-62% -$205K ﹤0.01% 3737
2021
Q1 		$336K Buy
16,491
+2,833
+21% +$53.1K ﹤0.01% 3435
2020
Q4 		$257K Sell
13,658
-1,880
-12% -$28.3K ﹤0.01% 3623
2020
Q3 		$200K Sell
15,538
-1,317
-8% -$17.1K ﹤0.01% 3848
2020
Q2 		$194K Buy
+16,855
New +$194K ﹤0.01% 4088
2019
Q4 		– Sell
-43
Closed – – 6559
2019
Q3 		$0 Buy
+43
New +$208 ﹤0.01% 6899
2019
Q2 		– Sell
-121
Closed -$1K – 7077
2019
Q1 		$1K Buy
+121
New +$482 ﹤0.01% 6914
2018
Q4 		– Sell
-53
Closed – – 7114
2018
Q3 		$0 Buy
+53
New +$173 ﹤0.01% 7242
2018
Q2 		– Sell
-6
Closed – – 7094
2018
Q1 		$0 Buy
+6
New +$14 ﹤0.01% 7179

Other funds holding INFU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Barclays's INFU Position: Q2 2026 in Review

Barclays reduced its InfuSystem Holdings (INFU) stake by 61% in Q2 2026, selling an estimated $135K and leaving 9,000 shares worth $86.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4104.

Barclays first reported a position in INFU in Q1 2018 and has held it in 25 quarters since. The position peaked at $374K in Q4 2021. 100 funds tracked by Wall St. Rank hold INFU as of Q2 2026.

  • Barclays held 9,000 shares of InfuSystem Holdings worth $86.8K as of Q2 2026.
  • Barclays sold 14,286 InfuSystem Holdings shares in Q2 2026, an estimated $135K.
  • InfuSystem Holdings made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4104 holding.
  • Barclays first reported a position in InfuSystem Holdings in Q1 2018 and has held it in 25 quarters since.
  • Barclays's InfuSystem Holdings position peaked at $374K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.